Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam T Hill

Showing results (11-20 of 129) with videos related to

Pageof 13
Sort By:
Expert Opinion on Investigational Drugs|August 6, 2017
Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasisManjit K Cartlidge, Adam T Hill
American Journal of Respiratory and Critical Care Medicine|March 4, 2014
Lung clearance index. A potential quantitative tool to assess treatment response in bronchiectasis?Adam T Hill, Patrick A Flume
Molecular Immunology|October 24, 2012
Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasisJames D Chalmers, Adam T Hill
BMJ (Clinical Research Ed.)|October 15, 2011
Investigation of "non-responding" presumed lower respiratory tract infection in primary careJames D Chalmers, Adam T Hill
Respirology (Carlton, Vic.)|August 20, 2019
Moving forward: Bronchiectasis and chronic suppurative lung disease in children and adults in the 21st centuryAdam T Hill, Anne B Chang
Thorax|March 7, 2013
Macrolides and pneumoniaJeremy Stuart Brown, Adam T Hill
Respirology (Carlton, Vic.)|March 26, 2018
Moving forward: Bronchiectasis and chronic suppurative lung disease in children and adults in the 21st centuryAdam T Hill, Anne B Chang
Current Pulmonology Reports|August 28, 2018
Risk of Development of Resistance in Patients with Non-Cystic Fibrosis Bronchiectasis Treated with Inhaled AntibioticsKate H Regan, Adam T Hill
Clinical Medicine (London, England)|May 14, 2009
Non-cystic fibrosis bronchiectasisMaeve P Murray, Adam T Hill
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
A powerful new severity score for community-acquired pneumonia but will anyone use it?James D Chalmers, Adam T Hill
Pageof 13

Showing results (11-20 of 129) with videos related to

Sort By:
Pageof 13
Expert Opinion on Investigational Drugs|August 6, 2017
Inhaled or nebulised ciprofloxacin for the maintenance treatment of bronchiectasisManjit K Cartlidge, Adam T Hill
American Journal of Respiratory and Critical Care Medicine|March 4, 2014
Lung clearance index. A potential quantitative tool to assess treatment response in bronchiectasis?Adam T Hill, Patrick A Flume
Molecular Immunology|October 24, 2012
Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasisJames D Chalmers, Adam T Hill
BMJ (Clinical Research Ed.)|October 15, 2011
Investigation of "non-responding" presumed lower respiratory tract infection in primary careJames D Chalmers, Adam T Hill
Respirology (Carlton, Vic.)|August 20, 2019
Moving forward: Bronchiectasis and chronic suppurative lung disease in children and adults in the 21st centuryAdam T Hill, Anne B Chang
Thorax|March 7, 2013
Macrolides and pneumoniaJeremy Stuart Brown, Adam T Hill
Respirology (Carlton, Vic.)|March 26, 2018
Moving forward: Bronchiectasis and chronic suppurative lung disease in children and adults in the 21st centuryAdam T Hill, Anne B Chang
Current Pulmonology Reports|August 28, 2018
Risk of Development of Resistance in Patients with Non-Cystic Fibrosis Bronchiectasis Treated with Inhaled AntibioticsKate H Regan, Adam T Hill
Clinical Medicine (London, England)|May 14, 2009
Non-cystic fibrosis bronchiectasisMaeve P Murray, Adam T Hill
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
A powerful new severity score for community-acquired pneumonia but will anyone use it?James D Chalmers, Adam T Hill
Pageof 13